相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Singular Location and Signaling Profile of Adenosine A(2A)-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum
Estefania Moreno et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Appraising the entourage effect: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Sandra Blasco-Benito et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Targeting the endocannabinoid system as a potential anticancer approach
Rico Schwarz et al.
DRUG METABOLISM REVIEWS (2018)
Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration
Kisha A. Scarlett et al.
MOLECULAR CANCER RESEARCH (2018)
Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer
Mohamad Elbaz et al.
ONCOTARGET (2017)
Impact of G protein-coupled receptor heteromers in endocrine systems
K. C. Jonas et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Genomic alterations of ERBB receptors in cancer: clinical implications
Rosalin Mishra et al.
ONCOTARGET (2017)
Advances in the management of HER2-positive early breast cancer
Jose Baselga et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Breast Cancer Molecular Stratification From Intrinsic Subtypes to Integrative Clusters
Hege G. Russnes et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Contribution of heteromerization to G protein-coupled receptor function
Supriya A. Gaitonde et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
G Protein-Coupled Receptor Heteromers
Ivone Gomes et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Antitumorigenic targets of cannabinoids - current status and implications
Robert Ramer et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression
Christopher J. Coke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer
Marta Hergueta-Redondo et al.
ONCOTARGET (2016)
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
Rebeca Diez-Alarcia et al.
FRONTIERS IN PHARMACOLOGY (2016)
Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization
Rafael Franco et al.
FRONTIERS IN PHARMACOLOGY (2016)
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Eduardo Perez-Gomez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
Xavier Vinals et al.
PLOS BIOLOGY (2015)
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Eduardo Perez-Gomez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
G-protein-coupled receptor type A heteromers as an emerging therapeutic target
Diego Guidolin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
N. A. Balenga et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Carlos L. Arteaga et al.
CANCER CELL (2014)
G-Protein-Coupled Receptor Heteromers as Key Players in the Molecular Architecture of the Central Nervous System
Marc Brugarolas et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
E. Martinez-Pinilla et al.
EXPERIMENTAL NEUROLOGY (2014)
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefania Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
G Protein-Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Sergi Ferre et al.
PHARMACOLOGICAL REVIEWS (2014)
Targeting the ERBB family in cancer: couples therapy
Niall Tebbutt et al.
NATURE REVIEWS CANCER (2013)
Fibroblast Growth Factor Receptor 1-5-Hydroxytryptamine 1A Heteroreceptor Complexes and Their Enhancement of Hippocampal Plasticity
Dasiel O. Borroto-Escuela et al.
BIOLOGICAL PSYCHIATRY (2012)
Cannabinoids: A new hope for breast cancer therapy?
Maria M. Caffarel et al.
CANCER TREATMENT REVIEWS (2012)
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
Lucia Callen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain
Ittai Bushlin et al.
PLOS ONE (2012)
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco et al.
NATURE REVIEWS CANCER (2012)
AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II
Raphael Rozenfeld et al.
EMBO JOURNAL (2011)
Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
Richard J. Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
GPR54 (KISS1R) Transactivates EGFR to Promote Breast Cancer Cell Invasiveness
Mateusz Zajac et al.
PLOS ONE (2011)
Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion
Mohd W. Nasser et al.
PLOS ONE (2011)
Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow?
Nigel J. Pyne et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Characterization of the A2AR-D2R interface Focus on the role of the C-terminal tail and the transmembrane helices
Dasiel O. Borroto-Escuela et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Maria M. Caffarel et al.
MOLECULAR CANCER (2010)
Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer
Christopher J. Fowler et al.
PLOS ONE (2010)
FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity
Marc Flajolet et al.
NATURE NEUROSCIENCE (2008)
erbB2 is required for G protein-coupled receptor signaling in the heart
Alejandra Negro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines:: Implication of epidermal growth factor receptor down-regulation and ceramide production
M Mimeault et al.
PROSTATE (2003)
分享论文
